<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
        <title><![CDATA[Sweden Herald - Bioarctic]]></title>
        <description><![CDATA[The latest Sweden Herald stories about Bioarctic, in English.]]></description>
        <link>https://swedenherald.com/organisation/bioarctic</link>
        <generator>RSS for Node and Next.js</generator>
        <lastBuildDate>Thu, 19 Nov 2026 18:19:09 GMT</lastBuildDate>
        <atom:link href="https://swedenherald.com/rss/organisation/bioarctic.xml" rel="self" type="application/rss+xml"/>
        <copyright><![CDATA[Sweden Herald]]></copyright>
        <language><![CDATA[en-US]]></language>
        <ttl>60</ttl>
        <item>
            <title><![CDATA[Australia Approves Leqembi for Early Alzheimer's Treatment]]></title>
            <description><![CDATA[Australia's medical authority has approved the substance lecanemab, which is sold under the name Leqembi, as a treatment for early Alzheimer's, writes the Swedish company Bioarctic in a press release.]]></description>
            <link>https://swedenherald.com/article/australia-approves-leqembi-for-early-alzheimers-treatment</link>
            <guid isPermaLink="true">https://swedenherald.com/article/australia-approves-leqembi-for-early-alzheimers-treatment</guid>
            <category><![CDATA[Business News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Wed, 24 Sep 2025 07:32:16 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/b8b6166e-8dd0-4d2f-bc0a-c3234bb2b79c/b8b6166e-8dd0-4d2f-bc0a-c3234bb2b79c.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/b8b6166e-8dd0-4d2f-bc0a-c3234bb2b79c/b8b6166e-8dd0-4d2f-bc0a-c3234bb2b79c.jpg" medium="image" type="image/jpeg" width="1600" height="1092"/>
        </item>
        <item>
            <title><![CDATA[EU Approves Alzheimer's Drug Lecanemab for Sale]]></title>
            <link>https://swedenherald.com/article/eu-greenlights-alzheimers-drug-lecanemab-for-sale-in-europe</link>
            <guid isPermaLink="true">https://swedenherald.com/article/eu-greenlights-alzheimers-drug-lecanemab-for-sale-in-europe</guid>
            <category><![CDATA[Business News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Tue, 15 Apr 2025 17:08:52 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/a61853b2-b7dc-400d-b1a7-aec2b81bdb4f/a61853b2-b7dc-400d-b1a7-aec2b81bdb4f.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/a61853b2-b7dc-400d-b1a7-aec2b81bdb4f/a61853b2-b7dc-400d-b1a7-aec2b81bdb4f.jpg" medium="image" type="image/jpeg" width="1600" height="1067"/>
        </item>
        <item>
            <title><![CDATA[Swedish drug candidate classified in the USA]]></title>
            <link>https://swedenherald.com/article/swedish-drug-candidate-classified-in-the-usa</link>
            <guid isPermaLink="true">https://swedenherald.com/article/swedish-drug-candidate-classified-in-the-usa</guid>
            <category><![CDATA[Business News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Mon, 17 Mar 2025 19:11:09 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/20243e03-6c85-4114-af3e-0d6417378a87/20243e03-6c85-4114-af3e-0d6417378a87.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/20243e03-6c85-4114-af3e-0d6417378a87/20243e03-6c85-4114-af3e-0d6417378a87.jpg" medium="image" type="image/jpeg" width="1600" height="1067"/>
        </item>
        <item>
            <title><![CDATA[Long wait for new Alzheimer's drug]]></title>
            <description><![CDATA[After years of waiting, the message came: the EU's pharmaceutical authority says yes to the drug lecanemab against Alzheimer's. But the question is which patients can be treated, and when – and if it is introduced in the country's regions at all.]]></description>
            <link>https://swedenherald.com/article/long-wait-for-new-alzheimers-drug</link>
            <guid isPermaLink="true">https://swedenherald.com/article/long-wait-for-new-alzheimers-drug</guid>
            <category><![CDATA[Sweden News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Fri, 27 Dec 2024 09:21:20 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/9722756e-1157-4ca5-adba-634af1689b28/9722756e-1157-4ca5-adba-634af1689b28.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/9722756e-1157-4ca5-adba-634af1689b28/9722756e-1157-4ca5-adba-634af1689b28.jpg" medium="image" type="image/jpeg" width="1600" height="1067"/>
        </item>
        <item>
            <title><![CDATA[Broad decline on the Stockholm stock exchange]]></title>
            <description><![CDATA[It was mainly red figures on the Stockholm Stock Exchange on Thursday. The broad OMXS index fell by 2.4 percent.]]></description>
            <link>https://swedenherald.com/article/decline-on-the-stock-exchange-expected-after-fed-decision</link>
            <guid isPermaLink="true">https://swedenherald.com/article/decline-on-the-stock-exchange-expected-after-fed-decision</guid>
            <category><![CDATA[Business News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Thu, 19 Dec 2024 07:17:37 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/54e9159b-d3ac-446e-95cc-d8c6d4c45583/54e9159b-d3ac-446e-95cc-d8c6d4c45583.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/54e9159b-d3ac-446e-95cc-d8c6d4c45583/54e9159b-d3ac-446e-95cc-d8c6d4c45583.jpg" medium="image" type="image/jpeg" width="1600" height="1067"/>
        </item>
        <item>
            <title><![CDATA[The UK Approves Alzheimer's Medication]]></title>
            <description><![CDATA[Despite a no in July from the European Medicines Agency EMA, the drug Leqembi is now approved for treatment of Alzheimer's patients in the United Kingdom.]]></description>
            <link>https://swedenherald.com/article/the-uk-approves-alzheimers-medication</link>
            <guid isPermaLink="true">https://swedenherald.com/article/the-uk-approves-alzheimers-medication</guid>
            <category><![CDATA[Business News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Sat, 24 Aug 2024 17:05:47 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/a763cf38-edec-482e-9f91-734728ab5341/a763cf38-edec-482e-9f91-734728ab5341.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/a763cf38-edec-482e-9f91-734728ab5341/a763cf38-edec-482e-9f91-734728ab5341.jpg" medium="image" type="image/jpeg" width="1024" height="683"/>
        </item>
        <item>
            <title><![CDATA[Alzheimer's medicine generates millions for Swedish Bioarctic]]></title>
            <link>https://swedenherald.com/article/alzheimers-medicine-generates-millions-for-swedish-bioarctic</link>
            <guid isPermaLink="true">https://swedenherald.com/article/alzheimers-medicine-generates-millions-for-swedish-bioarctic</guid>
            <category><![CDATA[Business News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Thu, 01 Aug 2024 12:17:49 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/df29cd46-ecb2-4c5f-a907-76783e01f0bf/df29cd46-ecb2-4c5f-a907-76783e01f0bf.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/df29cd46-ecb2-4c5f-a907-76783e01f0bf/df29cd46-ecb2-4c5f-a907-76783e01f0bf.jpg" medium="image" type="image/jpeg" width="1024" height="699"/>
        </item>
        <item>
            <title><![CDATA[Medicine Stop a Hard Blow for Alzheimer's Patients]]></title>
            <description><![CDATA[The disappointment is great since a new drug against Alzheimer's has been rejected by the EU's pharmaceutical authority. It is outrageous, says Liselotte Jansson at the Alzheimer's Foundation.]]></description>
            <link>https://swedenherald.com/article/medicine-stop-a-hard-blow-for-alzheimers-patients</link>
            <guid isPermaLink="true">https://swedenherald.com/article/medicine-stop-a-hard-blow-for-alzheimers-patients</guid>
            <category><![CDATA[Sweden News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Wed, 31 Jul 2024 03:30:28 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/fd8af7a3-2612-46a5-a315-ba7c2025ec44/fd8af7a3-2612-46a5-a315-ba7c2025ec44.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/fd8af7a3-2612-46a5-a315-ba7c2025ec44/fd8af7a3-2612-46a5-a315-ba7c2025ec44.jpg" medium="image" type="image/jpeg" width="1024" height="683"/>
        </item>
        <item>
            <title><![CDATA[Alzheimer's drug rejected by EMA]]></title>
            <description><![CDATA[The Alzheimer's drug lecanemab has not been approved by the European Medicines Agency EMA. The benefits are not considered to outweigh the potential drawbacks. A review of the decision will be requested, announces Swedish Bioarctic – whose share plummeted on the news.]]></description>
            <link>https://swedenherald.com/article/alzheimers-drug-rejected-by-ema</link>
            <guid isPermaLink="true">https://swedenherald.com/article/alzheimers-drug-rejected-by-ema</guid>
            <category><![CDATA[Sweden News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Fri, 26 Jul 2024 12:26:48 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/4a4205e3-ca46-4258-b19a-75219160f11f/4a4205e3-ca46-4258-b19a-75219160f11f.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/4a4205e3-ca46-4258-b19a-75219160f11f/4a4205e3-ca46-4258-b19a-75219160f11f.jpg" medium="image" type="image/jpeg" width="1024" height="699"/>
        </item>
        <item>
            <title><![CDATA[More approve Alzheimer's medication]]></title>
            <link>https://swedenherald.com/article/more-approve-alzheimers-medication</link>
            <guid isPermaLink="true">https://swedenherald.com/article/more-approve-alzheimers-medication</guid>
            <category><![CDATA[Business News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Fri, 12 Jul 2024 02:55:42 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/8e14f08f-ca04-48f6-a896-ec0b3b5aab24/8e14f08f-ca04-48f6-a896-ec0b3b5aab24.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/8e14f08f-ca04-48f6-a896-ec0b3b5aab24/8e14f08f-ca04-48f6-a896-ec0b3b5aab24.jpg" medium="image" type="image/jpeg" width="1024" height="683"/>
        </item>
    </channel>
</rss>